158 related articles for article (PubMed ID: 20609697)
1. One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.
Basile JN
Am J Med; 2010 Jul; 123(7 Suppl 1):S9-15. PubMed ID: 20609697
[TBL] [Abstract][Full Text] [Related]
2. The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.
Bakris GL; Basile JN; Giles TD; Taylor AA
Am J Med; 2010 Jul; 123(7 Suppl 1):S2-8. PubMed ID: 20609695
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
4. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
6. Vasodilating versus first-generation β-blockers for cardiovascular protection.
Fares H; Lavie CJ; Ventura HO
Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
[TBL] [Abstract][Full Text] [Related]
7. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
9. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
De Caterina AR; Leone AM
Am J Cardiol; 2010 May; 105(10):1433-8. PubMed ID: 20451690
[TBL] [Abstract][Full Text] [Related]
10. Evolving mechanisms of action of beta blockers: focus on nebivolol.
Mason RP; Giles TD; Sowers JR
J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
[TBL] [Abstract][Full Text] [Related]
11. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
[TBL] [Abstract][Full Text] [Related]
12. [Nebivolol: a beta blocker with vasodilator properties].
Waeber B
Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847
[TBL] [Abstract][Full Text] [Related]
13. The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome.
Taylor AA; Bakris GL
Am J Med; 2010 Jul; 123(7 Suppl 1):S21-6. PubMed ID: 20609696
[TBL] [Abstract][Full Text] [Related]
14. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of β-adrenergic receptor blockers in managing hypertension.
Poirier L; Lacourcière Y
Can J Cardiol; 2012 May; 28(3):334-40. PubMed ID: 22595449
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol: a review.
Cockcroft J
Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
[TBL] [Abstract][Full Text] [Related]
17. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
Yokota Y
J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular protection using beta-blockers: a critical review of the evidence.
Bangalore S; Messerli FH; Kostis JB; Pepine CJ
J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
20. [Vasodilating beta blockers as effective antihypertensive agents. Results of a multicenter observational study].
von Fallois J; Faulhaber HD
MMW Fortschr Med; 2000 Jun; 142(24):45. PubMed ID: 10895582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
